Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Biggest challenges facing young oncologists in 2030: How to address the next generation of anticancer treatments

The YO Boxing session: Is use of precision oncology in clinical practice mandatory or not to improve patient outcomes? Pro

Date

18 Oct 2020

Session

Biggest challenges facing young oncologists in 2030: How to address the next generation of anticancer treatments

Topics

Cytotoxic Therapy;  Targeted Therapy

Tumour Site

Presenters

Philippe Aftimos

Authors

P.G. Aftimos

Author affiliations

  • Clinical Trials Conduct Unit, Institute Jules Bordet, 1000 - Brussels/BE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.